I want to respond to some questions and comments I’ve received about our previous post about the ACell study we’re starting. The presentation at the ISHRS meeting was clear that the use of the ACell matrix with plucked hairs can stimulate growth. The process of doing this may not be as simple as it appears to be for many physicians.
First of all, the plucked hairs are usually a single hair with minimal tissue to protect it from harm when they are handled and/or exposed to the air during the transfer process. The surgeons who offer this have to be skilled to manage one-hair grafts without killing them. The application of the ACell Matrix has may nuances associated with it, so the doctors who “experiment” with this technique must build a process that works over and over again. It is also important to understand that the newly formed follicles will contain tissue from the donor area (the plucked hair) and tissue from the recipient area (the part of the follicle induced by the hair/ACell/tissue interaction). Since some of the follicle is derived the recipient area, we can’t be sure that it will cycle as a normal hair or even be totally permanent.
Over the years we have developed many processes that have led to many of today’s standards in hair transplantation, such as FUE, FUT, megasessions, and dense packing. We have consistently published our work in peer reviewed medical journals and have brought science to the world of clinical hair transplantation, advancing the standard of care over and over again. Our team (Dr. Jae Pak and myself in LA, Dr. Robert Bernstein and Dr. Eric Schweiger in NY) have put our heads together to build a process that, we believe, will afford our patients the best opportunity to benefit from the hair multiplication process and help the industry command the process better and with more certainty.
We are not of the belief that what we are doing with regard to hair multiplication is for everyone, or that everyone should rush into the process before the results of our work (and that of others) are completed. For select patients who are interested in participating in clinical trials or being treated outside the studies at this time, we would be happy to evaluate you to discuss this during a consultation. Remember, this process may not be for everyone at this time.